Special report
Mhamed Harif(Institut d’Hématologie et d’Oncologie Pédiatrique), Asmâa Quessar(University of Hassan II Casablanca), Lamia Torjemane(Tunis El Manar University), Dietger Niederwieser(Leipzig University of Applied Sciences), Nicolás Novitzky, Malek Benakli(University of Algiers Benyoucef Benkhedda), Eoin McGrath(European Molecular Biology Laboratory), Reguia Belkhedim(King Faisal Specialist Hospital & Research Centre), Paul W. Eldridge(University of North Carolina at Chapel Hill), Mahmoud Aljurf(King Faisal Specialist Hospital & Research Centre), Tarek Ben Othman(Tunis El Manar University), Abdellah Madani(Hôpital 20 Août), R Ahmed Nacer(University of Algiers Benyoucef Benkhedda), Lahoucine Mahmal(Cadi Ayyad University), Yoshihisa Kodera(Aichi Medical University), Nosakhare Bazuaye(University of Benin Teaching Hospital), Daniel Weisdorf(Children's Hospital of Wisconsin), Walid Rasheed(King Faisal Specialist Hospital & Research Centre), Syed Osman Ahmed(King Faisal Specialist Hospital & Research Centre), Jeff Szer(The Royal Melbourne Hospital)
Cited by 24
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k